Laws · Pennsylvania · November 16, 2026
Pennsylvania cannabis legalization is not a top priority for incoming Senate President Pro Tempore Jay Costa, a Democrat. Costa told ABC27 lawmakers will likely discuss it, but he pointed to affordability, a higher minimum wage and regulating AI data centers as more pressing. Democrats will hold both chambers next year, and Gov. Josh Shapiro backs legalization.
Why it matters: A Democratic Senate majority had raised hopes that Pennsylvania adult-use legalization might finally clear the Capitol. Costa's comments signal that timing is uncertain. For now, only registered medical patients can legally buy cannabis in the state, and anyone hoping for recreational access should expect a wait, not a fast vote.
Read moreSource: Ganjapreneur
Laws · Pennsylvania · November 16, 2026
Marijuana legalization in Pennsylvania is not a high priority for 2027, according to incoming Senate President Pro Tempore Jay Costa, a Democrat. He told WHTM-TV the issue will be discussed in coming months but not right away, even though Democrats just won control of the Senate and Gov. Josh Shapiro backs reform.
Why it matters: Advocates had hoped a Democratic Senate would quickly open the door to adult-use sales. Costa's comments suggest that timeline is slipping. For now, Pennsylvanians who want legal cannabis should expect the medical-only system to stay in place, and the border-state purchases that lawmakers cite are likely to continue into 2027.
Read moreSource: Marijuana Moment
Profiles · Pennsylvania · November 15, 2026
Jage Media, the company behind the MJ Unpacked event, has announced MJ Cultivate, a new trade show focused only on cannabis production. The event is set for April 27-28, 2027, in Philadelphia. Organizers say growing, extraction and manufacturing usually get only a slice of larger conferences. Founder and CEO George Jage says production deserves more attention.
Why it matters: A trade show built around production signals that the business side of cannabis is putting more weight on how products get made. For consumers and patients, the people behind consistent quality, cost control and efficiency are the ones shaping what lands on shelves. The show itself changes no rules or access, but it spotlights the supply side.
Read moreSource: mmjdaily.com
Laws · Pennsylvania, Virginia · November 13, 2026
Nearly every Republican in Congress backed with cannabis industry money through a Trump-linked PAC lost reelection in last week's midterms. Marijuana industry donations to the PAC, America First Agriculture Action, helped fund more than $4 million in ads and mailers for tough-race incumbents. One race remains uncalled, and the ads never mentioned cannabis.
Why it matters: The industry's money bought little electoral protection for the Republicans it helped, and several of those lawmakers have records against legalization. Consumers and patients should read this as a sign that donations alone do not guarantee friendlier votes. Congressional Republican leadership remains hostile to cannabis reform, even as the Trump administration pursues rescheduling.
Read moreSource: Marijuana Moment
Medical · Pennsylvania · November 12, 2026
Pennsylvania is building a reputation for medical marijuana research, with Philadelphia hosting five of the state's 10 certified academic clinical research centers. Researchers at Jefferson, Drexel and PCOM are studying pain, insomnia and anxiety among the more than 400,000 approved patients, using observational methods because federal limits make randomized trials hard.
Why it matters: Patients now get little hard evidence on which products work for which conditions. Pennsylvania's research centers aim to fill that gap, and Jefferson's Brooke Worster says their findings could add conditions to the state's qualifying list. They may also challenge the belief that more THC means more relief, as researchers warn about high-potency products.
Read moreSource: phillymag.com
Medical · Pennsylvania · November 11, 2026
A Pennsylvania doctor who won back his place in the state's medical marijuana program waited more than eight months for the Department of Health to reinstate him. Matthew Roman, once the top certifier of cards, was reinstated four days after Spotlight PA asked about his status. The department blamed an administrative error, a mis-toggled button.
Why it matters: Patients rely on a pool of approved doctors, and the decision signals that a restored, unrestricted medical license carries weight when the Health Department weighs a doctor's past discipline. The department now backs House Bill 33, which would let regulators set probation and certification limits. Any such rules could shape which doctors patients can see.
Read moreSource: spotlightpa.org
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report
Medical · Illinois, Mississippi, Pennsylvania · November 11, 2026
MoreBetter, a Philadelphia research company, has announced a medical cannabis registry program in Mississippi that will collect patient-reported outcomes from the state's registered patients. The company says it will track symptoms, prescription use and quality of life. Recruitment is expected to start in early 2027, and Pennsylvania and Illinois are named as possible next states.
Why it matters: Patients are often told little about how medical cannabis changes their prescription use or daily symptoms, because states rarely gather that evidence. A statewide dataset could eventually inform which conditions and products regulators scrutinize, and what lawmakers decide about program rules. For now it is a private research effort, and no findings exist yet.
Read moreSource: PR Newswire